2016年生命科学热点回眸

梁前进

doi:10.3981/j.issn.1000-7857.2017.01.007

PDF(3732 KB)

科技导报 ›› 2017, Vol. 35 ›› Issue (1) : 55-63. DOI: 10.3981/j.issn.1000-7857.2017.01.007

专题论文

2016年生命科学热点回眸

梁前进

作者信息 -

北京师范大学生命科学学院, 北京 100875

作者简介:

梁前进,教授,研究方向为分子细胞遗传与功能基因,电子信箱:lqj@bnu.edu.cn

Hot spots of life sciences in 2016

LIANG Qianjin

Author information -

College of Life Sciences, Beijing Normal University, Beijing 100875, China

摘要

生命的鲜活特点及其活动规律的复杂性，使得其研究中任一新发现都备受世人关注。2016年，生命科学领域的研究进展振奋人心。本文从不胜枚举的研究成果中选择了几例，介绍和评述了2016年在癌细胞诱导的内皮细胞死亡、耐药性基因突变的新型肺癌异位抑制剂、极大程度减少脱靶现象的基因靶向方案、利用双重受体改造型T细胞的精确肿瘤杀伤疗法、肿瘤高效免疫疗法、利用HIV病毒普效性抗体的艾滋病高效免疫疗法、可特异清除攻击病人自身组织淋巴细胞的自身免疫病疗法，以及晶体再生手术的革新、神经突触剪切机理的解析等方面的研究进展。特别是肿瘤治疗问题、基因编辑问题等，几乎一直保持着持续的热度，而在2016年又取得卓著成果。

Abstract

The live and fresh characteristics of life and the complexity of the laws of its activities make any new discoveries to attract worldwide attention. Research advances in the field of life sciences in 2016 have been soul-stirring. This paper selects several cases from the research results, which are too numerous to enumerate, to review the typical study progress in this year. The selected cases are:cancer cell induced death of endothelial cells, new type of ectopic inhibitor against drug resistance gene mutation lung cancers, gene targeting scheme that may greatly reduce off-targeting phenomenon, accurate tumor-killing therapy using modified T cells with dual receptor high efficient tumor immunological, therapy, high efficient AIDS immunological therapy, with HIV universal effect anti-virus antibodies, the therapy of autoimmune diseases with the removal of lymphocytes which attacking the patients' own tissues, as well as the crystal regeneration innovation, the resolution of the mechanism of synaptic pruning. Extraordinarily, the problems of tumor treatment, gene editing and so on, have maintained a constant heat, and in 2016, outstanding achievements were still made.

导出引用

梁前进. 2016年生命科学热点回眸[J]. 科技导报, 2017, 35(1): 55-63 https://doi.org/10.3981/j.issn.1000-7857.2017.01.007

LIANG Qianjin. Hot spots of life sciences in 2016[J]. Science & Technology Review, 2017, 35(1): 55-63 https://doi.org/10.3981/j.issn.1000-7857.2017.01.007

参考文献

[1] Strilic B, Yang L, Albarrán-Juárez J, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis[J]. Nature, 2016, 536(7615):215-218.
[2] Jia Y, Yun C H, Park E, et al. Overcoming EGFR (T790M) and EGFR (C797S) resistance with mutant-selective allosteric inhibitors[J]. Nature, 2016, 534(7605):129-132.
[3] Finlay M R V, Anderton M, Ashton S, et al. Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor[J]. Journal of Medicinal Chemistry, 2014, 57:8249-8267.
[4] Thress K S, Paweletz C P, Felip E, et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EG-FR T790M[J]. Nayure Medicine, 2015, 21:560-562.
[5] Gilbert L A, Larson M H, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes[J]. Cell, 2013, 154(2):442-451.
[6] 吴晓丽. 2015年生命科学热点回眸[J]. 科技导报, 2016, 34(1):23-35.
[7] Tan T, Chen Z, Lei Y, et al. A regulatory effect of INMAP on centromere proteins:antisense INMAP induces CENP-B variation and centromeric halo[J]. PLoS One, 2014, 9(3):e91937.
[8] Kleinstiver B P, Pattanayak V, Prew M S, et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects[J]. Nature, 2016, 529(7587):490-495.
[9] Morsut L, Roybal K T, Xiong X, et al. Engineering customized cell sensing and response behaviors using synthetic notch receptors[J]. Cell, 2016, 164(4):780-791.
[10] Escolano A, Steichen J M, Dosenovic P, et al. Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice[J]. Cell, 2016, 166(6):1445-1458.
[11] Ellebrecht C T, Bhoj V G, Nace A, et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease[J]. Science, 2016, 353(6295):179-184.
[12] Clemente-Casares X, Blanco J, Ambalavanan P, et al. Expanding antigen-specific regulatory networks to treat autoimmunity[J]. Nature, 2016, 530:434-440.
[13] Wei Y, Shen E, Zhao N, et al. Identification of a novel centrosomal protein CrpF46 involved in cell cycle progression and mitosis[J]. Expeirimental Cell Research, 2008, 314(8):1693-1707.
[14] Shen E, Lei Y, Liu Q, et al. Identification and characterization of INMAP, a novel interphase nucleus and mitotic apparatus protein that is involved in spindle formation and cell cycle progression[J]. Expeirimental Cell Research, 2009, 315(7):1100-1116.
[15] Zhou Y L, Chen Z, Lei Y, et al. INMAP, a novel truncated version of POLR3B, represses AP-1 and p53 transcriptional activity[J]. Molecular and Cellular Biochemistry, 2013, 374(1/2):81-89.
[16] Tan T, Chen Z, Lei Y, et al. A regulatory effect of INMAP on centromere proteins:Antisense INMAP induces CENP-B variation and centromeric halo[J]. PLoS One, 2014, 9(3):e91937.
[17] Zhu Y, Lei Y, Du B C, et al. INMAP overexpression inhibits cell proliferation, induces genomic instability and functions through p53/p21 pathways[J]. PLoS One, 2015, 10(1):e0115704.
[18] Lin H, Ouyang H, Zhu J, et al. Lens regeneration using endogenous stem cells with gain of visual function[J]. Nature, 2016, 531(7594):323-328.
[19] Sekar A, Bialas A R, de Rivera H, et al. Schizophrenia risk from complex variation of complement component 4[J]. Nature, 2016, 530(7589):177-183.
[20] Hong S, Beja-Glasser V F, Nfonoyim B M, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models[J]. Science, 2016, 352(6286):712-716.
[21] Lui H, Zhang J, Makinson S R, et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation[J]. Cell, 2016, 165(4):921-935.